Trade IMUX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Immunic, Inc. (IMUX) is trading at US$8.19, up 8.33% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$225.13M. Over the past 52 weeks, IMUX has traded between US$5.06 and US$17.43. On Syfe you can trade IMUX with $0 commission and add it to your watchlist.
| Previous close | US$7.56 |
|---|---|
| Market cap | US$225.13M |
| 52-week range | US$5.06 – US$17.43 |
| Volume | 510.81K |
| Exchange | US |
Immunic, Inc.
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company was founded in May 2003 and is headquartered in New York, NY.
Year: 2014
Roth Capital Partners Adjusts Price Target on Immunic to $29 From $19, Maintains Buy Rating
Sep 1, 12:03 PM · MT Newswires
Wedbush Initiates Immunic at Outperform With $45 Price Target
Aug 17, 11:01 AM · MT Newswires
Immunic Appoints Former Genentech Executive Erik Lundgren as CEO
May 27, 11:11 AM · MT Newswires
B. Riley Adjusts Price Target on Immunic to $27 From $40, Maintains Buy Rating
May 22, 11:54 AM · MT Newswires
Immunic Names Michael Bonney as Board Chair
May 19, 11:23 AM · MT Newswires
Immunic, Inc. (IMUX) stock is trading at US$8.19, +8.33% from the previous close of US$7.56.
The market cap for Immunic, Inc. (IMUX) stock is approximately US$225.13M.
The 52-week high for Immunic, Inc. (IMUX) stock is US$17.43.
The 52-week low for Immunic, Inc. (IMUX) stock is US$5.06.
Immunic, Inc. (IMUX) does not currently pay a dividend.
Stay on top of IMUX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
